Shanghai Pharmaceutical: the subsidiary amiodarone hydrochloride injection was approved for production

An Overview of China’s Robotaxi Industry in 2022 for Overseas Investors

This article discusses Robotaxi’s market size forecasting, commercialization barriers, relevant government policies and regulations, and the analysis of major players in China market. Also, the article includes some insights from Robotaxi executives and its supplier.

Exclusive Interview with Ray Hu, Founder and Managing Partner of Blue Lake Capital

Although the past two years have witnessed great changes in the world, the digitization trend remains unchanged. Of all the uncertainties facing us, digitization is still the surest opportunity nowadays.

Successful Multinational Corporations in China Series: Qualcomm China [2/2]

Since China's reform and opening-up, many multinational corporations and groups have achieved success in China. They have not only been successful in their fields, but some also benefitted from wise M&A moves or investments. To answer these questions EqualOcean launches its Successful Multinational Corporations in China and analyzes the critical points of investing in China for investors and people interested in such a topic.

NK Celltech Receives a Series A Round of Funding Worth More Than CNY 100 Million

NK Celltech recently received a Series A round of funding totaling more than CNY 100 million. Huagai Capital led this round of funding, which was followed by CASVC, Unifortune, 呈益资本, Sirius Capital, and QJ Capital.

GCP ClinPlus Announces The Completion of A Funding Round Worth More Than CNY 100 Million

​GCP ClinPlus has announced the completion of a CNY 100 million funding round. Tigermed (普瑞盛医药)led this round of financing, which was followed by 博荃百飞 and 杭州玖月创业投资.